Amarin Is A Sell Despite The Large Cash Balance
Source: SeekingAlpha
2025-06-06 14:46:45 ET
Amarin Corporation plc ( AMRN ) is a biotech company that has long been attempting to commercialize drugs based on an active ingredient found in fish oil. Amarin's aim is to improve outcomes for people with cardiovascular disease....
Read the full article on Seeking Alpha
For further details see:
Amarin Is A Sell Despite The Large Cash Balance
Amarin Corporation plc
NASDAQ: AMRN
AMRN Trading
-4.29% G/L:
$15.60 Last:
33,812 Volume:
$16.39 Open:
AMRN Latest News
March 07, 2026 01:35:00 am
Here's Why I Wouldn't Touch Amarin With a 10?Foot Pole Given Its Patent and Competition Risks
AMRN Stock Data
$312,618,004
18,426,477
1.2%
30
N/A
Pharmaceuticals
Healthcare
IE
Dublin 2
